{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:52:45Z","timestamp":1776847965767,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"DOI":"10.1007\/s40615-025-02685-2","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:23:26Z","timestamp":1759847006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disparities in Stage at Diagnosis and Cancer Progression by Race and Socioeconomic Deprivation: A Pan-Tumor Analysis in the US Community Oncology Setting"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-0604","authenticated-orcid":false,"given":"Andrew J.","family":"Osterland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther R.","family":"Smith-Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif A.","family":"Firozvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushal D.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2685_CR1","unstructured":"National Cancer Institute SEER Program. Cancer Stat Facts: Cancer Disparities. 2024; https:\/\/seer.cancer.gov\/statfacts\/html\/disparities.html. Accessed 28  June 2024."},{"issue":"10","key":"2685_CR2","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1158\/1055-9965.EPI-20-0007","volume":"29","author":"JL Moss","year":"2020","unstructured":"Moss JL, Pinto CN, Srinivasan S, Cronin KA, Croyle RT. Persistent poverty and cancer mortality rates: an analysis of county-level poverty designations. Cancer Epidemiol Biomarkers Prev. 2020;29(10):1949\u201354.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2685_CR3","first-page":"1","volume":"42","author":"AB Alpert","year":"2022","unstructured":"Alpert AB, Scout NFN, Schabath MB, Adams S, Obedin-Maliver J, Safer JD. Gender- and sexual orientation- based inequities: promoting inclusion, visibility, and data accuracy in oncology. Am Soc Clin Oncol Educ Book. 2022;42:1\u201317.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"2685_CR4","first-page":"31","volume":"70","author":"KI Alcaraz","year":"2020","unstructured":"Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31\u201346.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2685_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ijc.30087","volume":"139","author":"FP Boscoe","year":"2016","unstructured":"Boscoe FP, Henry KA, Sherman RL, Johnson CJ. The relationship between cancer incidence, stage and poverty in the United States. Int J Cancer. 2016;139(3):607\u201312.","journal-title":"Int J Cancer"},{"issue":"5","key":"2685_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1200\/OP.23.00810","volume":"20","author":"R Tucker-Seeley","year":"2024","unstructured":"Tucker-Seeley R, Abu-Khalaf M, Bona K, et al. Social determinants of health and cancer care: an ASCO policy statement. JCO Oncol Pract. 2024;20(5):621\u201330.","journal-title":"JCO Oncol Pract"},{"key":"2685_CR7","doi-asserted-by":"crossref","unstructured":"Wilson T, Osterland A, Markt S, et al. Social determinants of health in real-world evidence studies of early-stage cancer care: a systematic literature review. J Natl Compr Canc Netw. 2024;22(2.5):abstr CRE24\u2013046.","DOI":"10.6004\/jnccn.2023.7322"},{"key":"2685_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.amjcard.2021.02.013","volume":"147","author":"M Al-Sadawi","year":"2021","unstructured":"Al-Sadawi M, Hussain Y, Copeland-Halperin RS, et al. Racial and socioeconomic disparities in cardiotoxicity among women with HER2-positive breast cancer. Am J Cardiol. 2021;147:116\u201321.","journal-title":"Am J Cardiol"},{"key":"2685_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.breast.2021.07.018","volume":"59","author":"A Mo","year":"2021","unstructured":"Mo A, Chung J, Eichler J, et al. Breast cancer survivorship care during the COVID-19 pandemic within an urban New York hospital system. Breast. 2021;59:301\u20137.","journal-title":"Breast"},{"issue":"2","key":"2685_CR10","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.prro.2021.11.003","volume":"12","author":"M Yusuf","year":"2022","unstructured":"Yusuf M, Pan J, Rai SN, Eldredge-Hindy H. Financial toxicity in women with breast cancer receiving radiation therapy: final results of a prospective observational study. Pract Radiat Oncol. 2022;12(2):e79\u201389.","journal-title":"Pract Radiat Oncol"},{"key":"2685_CR11","unstructured":"The US Oncology Network.\u00a0https:\/\/usoncology.com\/our-company\/. Accessed 16 July 2024."},{"issue":"26","key":"2685_CR12","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible \u2014 the Neighborhood Atlas. N Engl J Med. 2018;378(26):2456\u20138.","journal-title":"N Engl J Med"},{"issue":"16_suppl","key":"2685_CR13","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1200\/JCO.2022.40.16_suppl.1577","volume":"40","author":"A Sanyal","year":"2022","unstructured":"Sanyal A, Bowen H, Janssen CW, Weber AA. Electronic capture of cancer-related distress in a community oncology program. J Clin Oncol. 2022;40(16_suppl):1577\u20131577.","journal-title":"J Clin Oncol"},{"issue":"22","key":"2685_CR14","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","volume":"331","author":"US Preventive Services Task Force","year":"2024","unstructured":"US Preventive Services Task Force. Screening for breast cancer: US preventive services task force recommendation statement. JAMA. 2024;331(22):1918\u201330.","journal-title":"JAMA"},{"issue":"1","key":"2685_CR15","first-page":"50","volume":"74","author":"AMD Wolf","year":"2024","unstructured":"Wolf AMD, Oeffinger KC, Shih TY, et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA Cancer J Clin. 2024;74(1):50\u201381.","journal-title":"CA Cancer J Clin"},{"key":"2685_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2024.1180","author":"P Ioerger","year":"2024","unstructured":"Ioerger P, Mills K, Wagoner SF, et al. Inequities associated with advanced stage at presentation of head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2024. https:\/\/doi.org\/10.1001\/jamaoto.2024.1180.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"2685_CR17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s40615-023-01625-2","volume":"11","author":"LL Dwyer","year":"2024","unstructured":"Dwyer LL, Vadagam P, Vanderpoel J, Cohen C, Lewing B, Tkacz J. Disparities in lung cancer: a targeted literature review examining lung cancer screening, diagnosis, treatment, and survival outcomes in the United States. J Racial Ethn Health Disparities. 2024;11(3):1489\u2013500.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"4","key":"2685_CR18","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s40615-020-00855-y","volume":"8","author":"D Hardy","year":"2021","unstructured":"Hardy D, Du DY. Socioeconomic and racial disparities in cancer stage at diagnosis, tumor size, and clinical outcomes in a large cohort of women with breast cancer, 2007\u20132016. J Racial Ethn Health Disparities. 2021;8(4):990\u20131001.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"4","key":"2685_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/107327481402100411","volume":"21","author":"VM Harvey","year":"2014","unstructured":"Harvey VM, Patel H, Sandhu S, Wallington SF, Hinds G. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes. Cancer Control. 2014;21(4):343\u20139.","journal-title":"Cancer Control"},{"issue":"10","key":"2685_CR20","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/2767-9764.CRC-24-0321","volume":"4","author":"E Heath","year":"2024","unstructured":"Heath E, Dyson G, Ribeiro JR, et al. Health disparities among patients with cancer who received molecular testing for biomarker-directed therapy. Cancer Res Commun. 2024;4(10):2598\u2013609.","journal-title":"Cancer Res Commun"},{"issue":"14","key":"2685_CR21","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.3390\/ijms23147779","volume":"23","author":"P Javadian","year":"2022","unstructured":"Javadian P, Xu C, Sjoelund V, Borden LE, Garland J, Benbrook DM. Identification of candidate biomarker and drug targets for improving endometrial cancer racial disparities. Int J Mol Sci. 2022;23(14):7779.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2685_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11606-017-4230-8","volume":"33","author":"E Byhoff","year":"2018","unstructured":"Byhoff E, Freund KM, Garg A. Accelerating the implementation of social determinants of health interventions in internal medicine. J Gen Intern Med. 2018;33(2):223\u20135.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"2685_CR23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/pds.5309","volume":"30","author":"N Sadetsky","year":"2021","unstructured":"Sadetsky N, Chuo CY, Davidoff AJ. Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer, bladder cancer, and melanoma: an electronic health record study. Pharmacoepidemiol Drug Saf. 2021;30(9):1233\u201341.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2685_CR24","doi-asserted-by":"publisher","first-page":"e211793","DOI":"10.1001\/jamanetworkopen.2021.1793","volume":"4","author":"DX Yang","year":"2021","unstructured":"Yang DX, Khera R, Miccio JA, et al. Prevalence of missing data in the National Cancer Database and association with overall survival. JAMA Netw Open. 2021;4(3):e211793.","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-025-02685-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:23:30Z","timestamp":1759847010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-025-02685-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":24,"alternative-id":["2685"],"URL":"https:\/\/doi.org\/10.1007\/s40615-025-02685-2","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board and Compliance\/Privacy approval was gained prior to initiation of the retrospective research. Since this project involved the analysis of existing data and records, study information was analyzed in such a manner that research participants could not be directly identified. Patient informed consent was not required due to the nature of the study design. Thus, exemption status and a waiver of informed consent were approved by The US Oncology, Inc. Institutional Review Board. Data were handled in compliance with HIPAA and the Health Information Technology for Economic and Clinical Health (HITECH) Act.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Poster presented at the ASCO Quality Care Symposium 2024 on September 27\u201328, 2024 in San Francisco, CA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conference Presentation"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Non-Financial Interests"}},{"value":"Financial interests: AO, YW, JP and GP are employees of McKesson\/Ontada. GP also reports employment with Texas Oncology. TW was an employee of McKesson\/Ontada at the time of the study, is a stockholder of McKesson, and reports leadership with Population Health Impact Institute and Trajectory Healthcare, LLC. ESH and KD are employees and own stock in Merck. KD also owns stock in AstraZeneca and Roche.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}